Merck & Co. is buying the developer of an experimental antiviral drug designed to prevent the flu, as the drugmaker aims to counter sales cliffs for two of its biggest drugs. Merck has been vocal ...
Halozyme HALO0.47%increase; green up pointing triangle was granted a preliminary injunction that would prevent Merck MRK-0.41%decrease; red down pointing triangle & Co. from distributing a formulation ...
Merck demonstrates excellence across the board through its resilient revenue mix, expanding profitability, and stellar capital allocation. MRK's innovation, highlighted by Keytruda's dominance and ...
Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs?
Merck's newest acquisition grants it access to a highly promising medicine. That could help it overcome the challenges its two biggest franchises are facing. Merck has other things going its way, ...
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. NEW ORLEANS — A pill designed to further lower ...
Oct 30 (Reuters) - Merck & Co (MRK.N), opens new tab posted higher third-quarter revenue on Thursday, as growth from its blockbuster cancer drug Keytruda offset falling sales from human papillomavirus ...
Merck reported third-quarter earnings and revenue that topped estimates in part due to strong demand for its cancer immunotherapy Keytruda, and narrowed its full-year profit outlook to reflect lower ...
As Merck looks for growth opportunities ahead of Keytruda’s tumble over the patent cliff, the company’s future now looks a bit brighter in the glow of two late-stage trial wins for cancer drug Welireg ...
A billion-dollar tsunami of life sciences development is hitting Virginia, with multinational pharmaceutical firm Merck as the latest to join the wave. The New Jersey-based pharma giant has begun ...
(AP Photo/Matt Rourke, File) (Matt Rourke, Copyright 2017 The Associated Press. All rights reserved.) Merck is set to create 500 new jobs in Virginia with the ...
Merck on Monday announced the groundbreaking of its new Virginia pharmaceutical manufacturing facility, a cornerstone of the company’s $70 billion U.S. investment strategy. The 400,000-square-foot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results